| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.08 |